Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 913814Generated: November 1, 2026

HCID 57546206, compound → HCID 57546006, compound

https://huagongshe.com/reaction/913814

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 57546206HCID 57546206—
ReactantHCID 57546251HCID 57546251—
ProductHCID 57546006HCID 57546006—

Reaction Steps

tert-Butyl 4-(4-fluorophenyl)-4-(((1-methyl-5-(trifluoromethyl)-1H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate and tert-Butyl 4-(4-fluorophenyl)-4-(((2-methyl-5-(trifluoromethyl)-2H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate. To a solution of tert-butyl 4-(4-fluorophenyl)-4-(((5-(trifluoromethyl)-1H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate (115 mg, 0.227 mmol) in dimethylformamide (2 mL) at 0° C. was added sodium hydride (60% in mineral oil, 18.1 mg, 0.45 mmol). After 5 min, the reaction was treated with iodomethane (0.028 mL, 0.45 mmol). After 30 min, the reaction was quenched by addition of saturated ammonium chloride and poured into diethyl ether. The organics were washed with water (3×), then brine, dried over magnesium sulfate, and concentrated. Column chromatography (25%→75% EtOAc/Hex) gave two fractions. The faster eluting fraction was concentrated to give tert-butyl 4-(4-fluorophenyl)-4-(((1-methyl-5-(trifluoromethyl)-1H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate (66 mg, 56%). The second fraction was concentrated to give tert-butyl 4-(4-fluorophenyl)-4-(((2-methyl-5-(trifluoromethyl)-2H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate (26 mg, 22%). tert-Butyl 4-(4-fluorophenyl)-4-(((1-methyl-5-(trifluoromethyl)-1H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate: 1H-NMR (CDCl3, 500 MHz) δ 8.03 (s, 1H), 7.98 (s, 1H), 7.31 (s, 1H), 7.17 (m, 2H), 6.91 (m, 2H), 4.72 (s, 2H), 4.03 (s, 3H), 3.67 (m, 2H), 3.46 (s, 2H), 3.02 (m, 2H), 2.10 (m, 2H), 1.79 (m, 2H), 1.44 (s, 9H); 13C-NMR (CDCl3, 126 MHz) δ 162.3, 160.3, 139.6, 135.4, 128.7, 128.6, 124.7 (q, J=272 Hz), 123.3 (q, J=32 Hz), 122.9, 121.8, 120.3 (q, J=2.9 Hz), 118.4 (q, J=4.8 Hz), 115.8, 115.6, 80.4, 71.9, 51.8, 46.3, 40.3, 32.9. tert-Butyl 4-(4-fluorophenyl)-4-(((2-methyl-5-(trifluoromethyl)-2H-indazol-7-yl)methoxy)methyl)piperidine-1-carboxylate: 1H-NMR (CDCl3, 500 MHz) δ 8.01 (s, 1H), 7.89 (s, 1H), 7.35 (m, 2H), 7.24 (s, 1H), 7.03 (m, 2H), 4.85 (s, 2H), 4.24 (s, 3H), 3.72 (m, 2H), 3.55 (s, 2H), 3.10 (m, 2H), 2.18 (m, 2H), 1.94 (m, 2H), 1.46 (s, 9H); 3C-NMR (CDCl3, 126 MHz) δ 162.4, 160.5, 155.1, 147.6, 138.7, 129.0, 128.9, 128.8, 125.6, 124.8 (q, J=273 Hz), 124.1 (q, J=32 Hz), 120.8, 118.8, 117.7 (q, J=4.8 Hz), 115.3, 115.1, 79.6, 79.4, 68.7, 41.4, 40.7, 40.2 (br), 32.2, 28.5.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08026257B2
Source datasetuspto-grants-2011_09
ORD IDord-03fd3b26114a41a0b0a34341a8395d94
Source noteuspto-grants-2011_09